heart failure 2016 update
TRANSCRIPT
2016 Focused Update On New Pharmacological Therapy For Heart Failure
2016 ACC/AHA/HFSA Focused Update On New Pharmacological Therapy For Heart Failure and 2016 ESC guidelines on the Diagnosis And Treatment Of Acute And Chronic Heart Failure NEERAJ VARYANI
NYHA FUNCTIONAL CLASSIFICATION
STAGES OF HEART FAILURE
DEFINITIONS OF HFrEF, HFmrEF and HFpEF
MAJOR CLINICAL TRIALS OF THERAPEUTIC INTERVENTION IN HFrEF
MAJOR CLINICAL TRIALS OF THERAPEUTIC INTERVENTION IN HFrEF
DATA SUPPLEMENT OF ACC/AHA/HFSA DOCUMENT ON ARNI
DATA SUPPLEMENT OF ACC/AHA/HFSA DOCUMENT ON COMPARISON OF ARNI WITH ACE
DATA SUPPLEMENT OF ACC/AHA/HFSA DOCUMENT ON COMPARISON OF ARNI WITH ACE
DATA SUPPLEMENT OF ACC/AHA/HFSA DOCUMENT FOR IVABRADINE
DATA SUPPLEMENT OF ACC/AHA/HFSA DOCUMENT ON IVABRADINE
DATA SUPPLEMENT OF ACC/AHA/HFSA DOCUMENT ON IVABRADINE
MAJOR TRIALS OF THERAPEUTIC INTERVENTION IN HFrEF
PHASE 2 AND PHASE 3 CLINICAL TRIALS IN HFmrEF AND HFpEF
CLASS OF RECOMMENDATIONS AND LEVEL OF EVIDENCE FOR THE ESC DOCUMENT
THERAPEUTIC ALGORITHM FOR A PATIENT WITH HFrEF
EVIDENCE BASED DOSES OF ARNI AND IVABRADINE
ESC GUIDELINES 2016 – WHAT IS THE PRESENT STATUS OF THESE NOVEL TREATMENTS
ACC/AHA/HFSA CLASS OF RECOMMENDATION AND LEVEL OF EVIDENCE
RAAS INHIBITION IN ACC/AHA/HFSA UPDATE 2016
CONTD..
ACC/AHA/HFSA 2016 RECOMMENDATION FOR IVABRADINE